The aquatic veterinary market size is projected to grow from US$ 1,450.44 million in 2022 to US$ 1,934.33 million by 2030; the market is estimated to record a CAGR of 3.7% during 2022–2030.
Market Insights and Analyst View:
The aquatic veterinary medicine discipline involves complete healthcare for aquatic animals, including whales, sharks, alligators, mollusks, and penguins. The aquatic veterinary market growth is attributed to initiatives by the governments of various countries to develop their respective aquaculture industries and the surging demand for food products derived from aquatic animals. Further, ongoing efforts for the development of novel fish vaccines are expected to create ample opportunities for market players in the coming years.
Growth Drivers and Restraints:
The high demand for seafood and the decreasing annual catch of wild fish are crucial factors that can drive the growth of the aquaculture industry at an exponential rate. Thus, governments are taking initiatives to improve and support the growth of the aquacultural industry.
Following are a few recent initiatives:
- In February 2021, the Foundation for Food & Agriculture Research (FFAR) raised funds of US$ 790,326 to create a vaccine delivery system to prevent the spread of tilapia lake virus infections and other diseases in the aquaculture sector.
- In January 2022, Benchmark Animal Health, a top aquaculture biotechnology company, and Cermaq Group AS, a world-leading salmon farming company, received US$ 0.4 million (NOK 4.2 million) in funding from the Norwegian Research Council to support a collaborative research project for the production of a vaccine against Tenacibaculum bacteria-caused salmon diseases.
- In January 2023, the European Commission funded US$ 7.88 million to the PerformFISH project, which was initiated to explore and tackle the major causes of stagnancy in the Mediterranean Marine Fish Farming (MMFF) sector. The PerformFISH has been making efforts to manage challenges associated with sea bass and sea bream in Mediterranean aquaculture.
The European Union (EU), in the framework of Horizon 2020, funded Mediterranean Aquaculture Integrated Development (Media)—a four-year Research and Innovation Action (RIA) project that was jointly approved along with PerformFISH under the program SFS-23-2016—for improving the technical performance of Mediterranean aquaculture. MedAID aims to improve the sustainability and competitiveness of the Mediterranean marine fish-farming sector throughout the value chain. Thus, an increase in government initiatives to support developments in the aquaculture industry drives the growth of the aquatic veterinary market. Further, the aquatic veterinary market trends include the development of novel DNA-based vaccines against different fish pathogens.
Fish vaccines developed for commercial use must be approved by an appropriate national or regional authority. Before the use or trade of vaccines, it is mandatory to follow specific rules and recommendations set by relevant competent authorities. The legislation, requirements, and involved regulatory bodies for authorization may vary by country. In the EU, fish vaccines cannot be authorized by a national competent authority. The European Medicines Agency authorizes them for the entire European Union. The cost of producing vaccines is high as the EU has strict guidelines for vaccine manufacturers regarding good manufacturing practices (GMP). Fish vaccines have a smaller market than other animal vaccines, and their development costs are higher than those of vaccines for other animal species. In the US, the FDA approves fish vaccines. Development of fish vaccines takes more than 10 years or longer and costs nearly US$ 10–20 million. Additionally, the approval process is time-consuming, which prevents new players from entering the market. Thus, a stringent regulatory framework hinders the development and commercialization of fish vaccines, which hampers the aquatic veterinary market growth.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Aquatic Veterinary Market: Strategic Insights
Market Size Value in US$ 1,450.44 million in 2022 Market Size Value by US$ 1,934.33 million by 2030 Growth rate CAGR of 3.7% from 2022 to 2030 Forecast Period 2022-2030 Base Year 2022
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Aquatic Veterinary Market: Strategic Insights
| Market Size Value in | US$ 1,450.44 million in 2022 |
| Market Size Value by | US$ 1,934.33 million by 2030 |
| Growth rate | CAGR of 3.7% from 2022 to 2030 |
| Forecast Period | 2022-2030 |
| Base Year | 2022 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Report Segmentation and Scope:
The aquatic veterinary market analysis has been carried out by considering the following segments: type, disease source, species, and route of administration. Based on type, the market is bifurcated into diagnostics and treatments. By species, the market is divided into fish, crustaceans, mollusks, and others. Based on disease source, the market is differentiated into bacteria, viruses, parasites, and others. In terms of route of administration, the market is segmented into water medication, medicated feed, and others. Based on geography, the aquatic veterinary market is segmented into North America (US, Canada, and Mexico), Europe (Germany, France, Italy, UK, Russia, and Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and Rest of Asia Pacific), the Middle East & Africa (South Africa, Saudi Arabia, UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Segmental Analysis:
The aquatic veterinary market research, based on type, is segmented into diagnostics and treatments. In 2022, the treatment segment accounted for a larger share of the market. The market for this segment is expected to grow at a higher CAGR from 2022 to 2030.
Based on species, the market is segmented into fish, crustaceans, mollusks, and others. The fish segment held the largest aquatic veterinary market share in 2022. It is expected to register the highest CAGR from 2022 to 2030.
Based on disease sources, the market is segmented into bacteria, viruses, parasites, and others. The bacteria segment accounted for the largest aquatic veterinary market share in 2022. It is projected to register the highest CAGR during 2022–2030.
Based on the route of administration, the aquatic veterinary market is segmented into water medication, medicated feed, and others. The water medication segment accounted for the largest share of the market in 2022. The same segment is projected to register the highest CAGR from 2022 to 2030.
Aquatic Veterinary Market, by Type – 2022 and 2030
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Regional Analysis:
The scope of the aquatic veterinary market report entails North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. In 2022, North America accounted for the largest market share. The North America aquatic veterinary market is segmented into the US, Canada, and Mexico. The growth of market in the US is attributed to the flourishing aquaculture industry and surging demand for aquatic animal-derived food products.
According to the Fisheries of the US 2020 report, commercial fishermen in the US reported a yield of 8.4 billion pounds valued at US$ 4.7 billion in 2020. Anglers in the country took nearly 200 million trips for recreational fisheries in 2020. These recreational anglers caught approximately 1 billion fish and released 65% of those caught. The overall recreational harvest was estimated at 344 million fish weighing 353 million pounds. Thus, the flourishing aquaculture industry fuels the growth of the aquatic veterinary market in the US.
- In September 2020, the Virbac Group acquired various tilapia vaccines from Ictyogroup, an animal health company specializing in R&D biology. The group received rights for the distribution and marketing of these registered, autogenous vaccines worldwide. The two companies had a partnership for the development of new formulations and new vaccines for the Aqua Virbac division. The agreement also allowed the transfer of several employees specialized in technical marketing support and R&D biology from Ictyogroup to Virbac.
- In July 2020, Zoetis acquired the Fish Vet Group from Benchmark Holdings, PLC to make a strategic addition to its pharma business. The pharmaceutical business of Zoetis commercializes and develops fish vaccines, and offers vaccination and diagnostic services for aquaculture. The acquisition of Fish Vet Group helped Zoetis enhance its diagnostics expertise and testing services, including environmental testing at Pharmaq’s reference lab.
Thus, strategic initiatives by various market players in the US aquaculture industry bolster the aquatic veterinary market in the US.
Industry Developments and Future Opportunities:
The aquatic veterinary market forecast can help stakeholders in this marketplace plan their growth strategies. A few initiatives taken by key players operating in the aquatic veterinary market are listed below:
- In September 2020, the AKVA Group and Vikings signed a design and cooperation agreement to design several land-based salmon farms in the Middle East. AKVA Group provides extensive experience in designing, constructing, and operating modern land-based fish farming.
- In May 2020, the AKVA group acquired Sperre, located in the Notodden town of the Norwegian subsea cluster. The company has extensive experience developing and manufacturing various advanced ROV solutions for aquaculture, oil service, and marine industries.
- In November 2022, Elanco Animal Health Inc and Ginkgo Bioworks launched BiomEdit to discover, develop, and introduce novel probiotics, bioactive molecules, engineered microbial medicines, and microbial monitoring services for animal health.
- In November 2023, Merck Animal Health introduced two training modules in its Fish Welfare series to empower aquaculture businesses and conservation fish communities with training and best practices for improved fish welfare. The training programs were also designed to complement and help fulfill the animal care requirements of aquaculture certification and stewardship programs.
Competitive Landscape and Key Companies:
Esox, Zoetis, Elanco Animal Health, Merck KgaA, Virbac Animal Health, Phbro Animal Health Corporation, Aquatic Diagnostics Ltd, Thermo Fisher Scientific, Ceva, and HIPRA are among the prominent players profiled in the aquatic veterinary market report. A few of the growth strategies embraced by these companies to promote their growth are launches, expansion, and relocation. Elanco Animal Health Inc. is among the companies that havehas been implementing organic strategies, which, in turn, have brought about various changes in contributed significantl y to the global health economics and outcomes research services market. . In addition to those mentioned above, several other players have been studied and analyzed during the study to get a holistic view of the market and its ecosystem.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Species, Disease Source, Route of Administration, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The global aquatic veterinary market, by type, is segmented into diagnostics and treatments. In 2022, the treatment segment accounted for a larger share of the market. The market for this segment is expected to grow at a higher CAGR from 2022 to 2030.
The global aquatic veterinary market majorly consists of the players such as Esox, Zoetis, Elanco Animal Health, Merck KgaA, Virbac Animal Health, Phbro Animal Health Corporation, Aquatic Diagnostics Ltd, Thermo Fisher Scientific, Ceva, and HIPRA
The aquatic veterinary market size is growing with initiatives taken by various country governments to develop their respective aquaculture industries and the surging demand for food products derived from aquatic animals. Further, ongoing efforts for the development of novel fish vaccines are expected to create ample opportunities for the aquatic veterinary market in the coming years.
The aquatic veterinary medicine discipline involves complete healthcare for aquatic animals, including whales, sharks, alligators, mollusks, and penguins. The aquatic veterinary market size is growing with initiatives taken by various country governments to develop their respective aquaculture industries and the surging demand for food products derived from aquatic animals.
The List of Companies - Aquatic Veterinary Market
- Esox
- Zoetis
- Elanco Animal Health
- Merck KgaA
- Virbac Animal Health
- Phbro Animal Health Corporation
- Aquatic Diagnostics Ltd
- Thermo Fisher Scientific
- Ceva
- HIPRA
- Fish Vet Group
- MELAFIX
- Cenavisa Animal Health & Aquaculture
- Hebei Veyong pharmaceutical Co., Ltd.
- MED-VET BIOLINKS PRIVATE LIMITED
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Aquatic Veterinary Market
Feb 2024
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2024
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Feb 2024
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Feb 2024
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2024
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2024
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Feb 2024
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Feb 2024
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)